Edmund Dunn - Principal Accounting Officer at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Principal Accounting Officer
Stock Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Edmund Dunn - trading volume in the past year for Monte Rosa Therapeutics, Inc.

Holdings reported by Edmund Dunn for Monte Rosa Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 13.9K $53.4K $3.83 Jul 5, 2024 Direct
Stock Option (Right to Buy) 35.9K Jan 2, 2024 Direct Common Stock

Transactions reported by Edmund Dunn for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.